These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6494575)
1. Predictive relevance for clinical outcome of in vitro sensitivity evaluated through antimetabolic assay. Silvestrini R; Sanfilippo O; Daidone MG; Zaffaroni N Recent Results Cancer Res; 1984; 94():140-50. PubMed ID: 6494575 [No Abstract] [Full Text] [Related]
2. Development of a nucleotide precursor incorporation assay for testing drug sensitivity of human tumors. Sanfilippo O; Daidone MG; Zaffaroni N; Silvestrini R Recent Results Cancer Res; 1984; 94():127-39. PubMed ID: 6494574 [No Abstract] [Full Text] [Related]
3. Cell kinetics and in vitro chemosensitivity as a tool for improved management of patients. Silvestrini R; Daidone MG; Costa A; Sanfilippo O Eur J Cancer Clin Oncol; 1985 Mar; 21(3):371-8. PubMed ID: 4007012 [No Abstract] [Full Text] [Related]
4. In vitro characterization of new antiestrogens in human mammary tumor cells. Eppenberger U; Küng W; Löser R; Roos W Recent Results Cancer Res; 1984; 94():245-52. PubMed ID: 6494585 [No Abstract] [Full Text] [Related]
5. A short-term in vitro drug-screening assay for cancer chemotherapy. Chen SL; Snoga JR; Croft H Clin Chem; 1982 Sep; 28(9):1852-6. PubMed ID: 6751606 [TBL] [Abstract][Full Text] [Related]
6. In vitro chemosensitivity assay based on the concept of total tumor cell kill. Weisenthal LM; Shoemaker RH; Marsden JA; Dill PL; Baker JA; Moran EM Recent Results Cancer Res; 1984; 94():161-73. PubMed ID: 6494576 [No Abstract] [Full Text] [Related]
7. In vitro activity of alkylating agents on human tumors as measured by a short-term antimetabolic assay. Zaffaroni N; Silvestrini R; Sanfilippo O; Daidone MG; Gasparini G Tumori; 1985 Dec; 71(6):555-61. PubMed ID: 4082288 [TBL] [Abstract][Full Text] [Related]
8. Tissue-culture microtest for predicting response of human cancer to chemotherapy. Holmes HL; Little JM Lancet; 1974 Oct; 2(7887):985-7. PubMed ID: 4138888 [No Abstract] [Full Text] [Related]
9. Chemotherapy in older women with breast cancer. Dizdar O; Dede DS; Altundag K N Engl J Med; 2009 Sep; 361(10):1023; author reply 1023-4. PubMed ID: 19731412 [No Abstract] [Full Text] [Related]
10. Comparison of an antimetabolic assay and an antiproliferative assay, both using 3H-thymidine incorporation, to test drug sensitivity of human tumors. Zaffaroni N; Silvestrini R; Grignolio E; Villa R; DeMarco C Int J Cell Cloning; 1988 Nov; 6(6):392-403. PubMed ID: 2466088 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity and variability of test results as limiting factors for predictive assays. Schlag P; Flentje D Recent Results Cancer Res; 1984; 94():191-6. PubMed ID: 6494579 [No Abstract] [Full Text] [Related]
12. Biochemical short-term predictive assay: results of correlative trials in comparison to other assays. Kaufmann M Recent Results Cancer Res; 1984; 94():151-60. PubMed ID: 6387831 [No Abstract] [Full Text] [Related]
13. [Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)]. Mallmann P; Nitschmann S Internist (Berl); 2010 Jul; 51(7):923-4. PubMed ID: 20544172 [No Abstract] [Full Text] [Related]
14. Using a mammalian cell cycle simulation to interpret differential kinase inhibition in anti-tumour pharmaceutical development. Chassagnole C; Jackson RC; Hussain N; Bashir L; Derow C; Savin J; Fell DA Biosystems; 2006; 83(2-3):91-7. PubMed ID: 16236428 [TBL] [Abstract][Full Text] [Related]
15. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Tanigawa N; Kern DH; Hikasa Y; Morton DL Cancer Res; 1982 Jun; 42(6):2159-64. PubMed ID: 7074595 [No Abstract] [Full Text] [Related]
16. [Clonogenic cells in human tumors and the sensitivity to chemotherapy]. Potapov SL; Korman DB Eksp Onkol; 1986; 8(1):7-12. PubMed ID: 3512239 [TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of cell kinetics in breast cancer. Amadori D; Volpi A; Callea A; Amaducci L; Morgagni S; Magni E; Nanni O Ann N Y Acad Sci; 1993 Nov; 698():186-92. PubMed ID: 8279756 [No Abstract] [Full Text] [Related]
18. [The potential of capecitabine (Xeloda) in the treatment of disseminated solid tumors]. Moiseenko VM; Semenova AI; Orlova RV Vopr Onkol; 2001; 47(1):112-9. PubMed ID: 11317529 [No Abstract] [Full Text] [Related]
19. Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity. Sanfilippo O; Silvestrini R; Zaffaroni N; Piva L; Pizzocaro G Cancer; 1986 Oct; 58(7):1441-7. PubMed ID: 3017538 [TBL] [Abstract][Full Text] [Related]
20. Predictive tests and infrequent events in cancer chemotherapy. Rozencweig M; Staquet M Recent Results Cancer Res; 1984; 94():174-83. PubMed ID: 6387832 [No Abstract] [Full Text] [Related] [Next] [New Search]